Search Results - "Chen, Michael P."

Patterns of treatment interruption among patients with multidrug-resistant TB (MDR TB) and association with interim and final treatment outcomes by Podewils, Laura Jean, Gler, Maria Tarcela S, Quelapio, Maria Imelda, Chen, Michael P

“…The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-factorial and complex. Identifying patterns of treatment…”
Get full text

A national study of socioeconomic status and tuberculosis rates by country of birth, United States, 1996-2005 by Olson, Nicole A, Davidow, Amy L, Winston, Carla A, Chen, Michael P, Gazmararian, Julie A, Katz, Dolores J

“…Tuberculosis (TB) in developed countries has historically been associated with poverty and low socioeconomic status (SES). In the past quarter century, TB in…”
Get full text

Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons by Sterling, Timothy R, Scott, Nigel A, Miro, Jose M, Calvet, Guilherme, La Rosa, Alberto, Infante, Rosa, Chen, Michael P, Benator, Debra A, Gordin, Fred, Benson, Constance A, Chaisson, Richard E, Villarino, M Elsa

“…OBJECTIVE:Compare the effectiveness, tolerability, and safety of 3 months of weekly rifapentine and isoniazid under direct observation (3HP) versus 9 months of…”
Get full text

Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection: A Randomized Trial by Belknap, Robert, Holland, David, Feng, Pei-Jean, Millet, Joan-Pau, Caylà, Joan A, Martinson, Neil A, Wright, Alicia, Chen, Michael P, Moro, Ruth N, Scott, Nigel A, Arevalo, Bert, Miró, José M, Villarino, Margarita E, Weiner, Marc, Borisov, Andrey S

“…Expanding latent tuberculosis treatment is important to decrease active disease globally. Once-weekly isoniazid and rifapentine for 12 doses is effective but…”
Get full text

Unexpected decline in tuberculosis cases coincident with economic recession - United States, 2009 by Winston, Carla A, Navin, Thomas R, Becerra, Jose E, Chen, Michael P, Armstrong, Lori R, Jeffries, Carla, Yelk Woodruff, Rachel S, Wing, Jessie, Starks, Angela M, Hales, Craig M, Kammerer, J Steve, Mac Kenzie, William R, Mitruka, Kiren, Miner, Mark C, Price, Sandy, Scavotto, Joseph, Cronin, Ann M, Griffin, Phillip, LoBue, Philip A, Castro, Kenneth G

“…Since 1953, through the cooperation of state and local health departments, the U.S. Centers for Disease Control and Prevention (CDC) has collected information…”
Get full text

Symptoms and Systemic Drug Reactions in Persons Receiving Weekly Rifapentine Plus Isoniazid (3HP) Treatment for Latent Tuberculosis Infection by Sadowski, Claire, Belknap, Robert, Holland, David P, Moro, Ruth N, Chen, Michael P, Wright, Alicia, Millet, Joan Pau, Caylà, Joan A, Scott, Nigel A, Borisov, Andrey, Gandhi, Neel R

“…Abstract Background Three months of weekly rifapentine plus isoniazid (3HP) therapy for latent tuberculosis infection (LTBI) is recommended worldwide. The…”
Get full text

Estimating county-level vaccination coverage using small area estimation with the National Immunization Survey-Child by Seeskin, Zachary H., Ganesh, Nadarajasundaram, Maitra, Poulami, Herman, Peter, Wolter, Kirk M., Copeland, Kennon R., English, Ned, Chen, Michael P., Singleton, James A., Santibanez, Tammy A., Yankey, David, Elam-Evans, Laurie D., Sterrett, Natalie, Smith, Chalanda S., Gipson, Kevin, Meador, Seth

“…•Produce estimates of county-level vaccination coverage for children up to age two.•Combine NIS-Child direct survey estimates with model-based…”
Get full text

Isoniazid and Rifampin-Resistance Mutations Associated With Resistance to Second-Line Drugs and With Sputum Culture Conversion by Click, Eleanor S, Kurbatova, Ekaterina V, Alexander, Heather, Dalton, Tracy L, Chen, Michael P, Posey, James E, Ershova, Julia, Cegielski, J Peter

“…Abstract Background Mutations in the genes inhA, katG, and rpoB confer resistance to anti-tuberculosis (TB) drugs isoniazid and rifampin. We questioned whether…”
Get full text

A Bayesian analysis of the 2009 decline in tuberculosis morbidity in the United States by Chen, Michael P., Shang, Nong, Winston, Carla A., Becerra, Jose E.

“…Although annual data are commonly used to model linear trends and changes in trends of disease incidence, monthly data could provide additional resolution for…”
Get full text

Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons by Sterling, Timothy R, Scott, Nigel A, Miro, Jose M, Calvet, Guilherme, La Rosa, Alberto, Infante, Rosa, Chen, Michael P, Benator, Debra A, Gordin, Fred, Benson, Constance A, Chaisson, Richard E, Villarino, M Elsa

“…OBJECTIVE:Compare the effectiveness, tolerability, and safety of three months of weekly rifapentine plus isoniazid under direct observation (3HP) vs. 9 months…”
Get full text

Reply to Soman et al, Alffenaar et al, Metcalfe et al, and Raoult by Cegielski, J. Peter, Chen, Michael P., Tupasi, Thelma E., Leimane, Vaira, Volchenkov, Grigory V.

Get full text

Efficacy of the Male Latex Condom and of the Female Polyurethane Condom as Barriers to Semen during Intercourse: A Randomized Clinical Trial by Macaluso, Maurizio, Blackwell, Richard, Jamieson, Denise J., Kulczycki, Andrzej, Chen, Michael P., Akers, Rachel, Kim, Dhong-jin, Duerr, Ann

“…In this 2000–2001 study, the authors compared the effectiveness of the male latex condom and the female polyurethane condom by assessing frequency and types of…”
Get full text

Confidence intervals and statistical testing for ratio measures of percent change by Winston, Carla A., Hill, Andrew N., Chen, Michael P., Shang, Nong, Becerra, José E.

“…In public health and medical research, ratio measures of percent change relative to baseline are often used to express a change in disease incidence…”
Get full text

Self-Reported Mechanical Problems During Condom Use and Semen Exposure: Comparison of Two Randomized Trials in the United States of America and Brazil by CHEN, MICHAEL P., MACALUSO, MAURIZIO, BLACKWELL, RICHARD, GALVAO, LOREN, KULCZYCKI, ANDRZEJ, DIAZ, JUAN, JAMESON, DENISE J., DUERR, ANN

“…Objectives/Goal: To compare self-reported condom use problems and objectively determined semen exposure in 2 populations. Study Design: Two randomized…”
Get full text

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis by Cegielski, J. Peter, Dalton, Tracy, Yagui, Martin, Wattanaamornkiet, Wanpen, Volchenkov, Grigory V., Via, Laura E., Van Der Walt, Martie, Tupasi, Thelma, Smith, Sarah E., Odendaal, Ronel, Leimane, Vaira, Kvasnovsky, Charlotte, Kuznetsova, Tatiana, Kurbatova, Ekaterina, Kummik, Tiina, Kuksa, Liga, Kliiman, Kai, Kiryanova, Elena V., Kim, HeeJin, Kim, Chang-ki, Kazennyy, Boris Y., Jou, Ruwen, Huang, Wei-Lun, Ershova, Julia, Erokhin, Vladislav V., Diem, Lois, Contreras, Carmen, Cho, Sang Nae, Chernousova, Larisa N., Chen, Michael P., Caoili, Janice Campos, Bayona, Jaime, Akksilp, Somsak

“…Background. Increasing access to drugs for the treatment of multidrug-resistant (MDR) tuberculosis is crucial but could lead to increasing resistance to these…”
Get full text

Patterns of Treatment Interruption among Patients with Multidrug-Resistant TB (MDR TB) and Association with Interim and Final Treatment Outcomes. e70064 by Podewils, Laura Jean, Gler, Maria TarcelaS, Quelapio, Maria Imelda, Chen, Michael P

“…Background The reasons that patients with multidrug-resistant tuberculosis (MDR TB) miss treatment are multi-factorial and complex. Identifying patterns of…”
Get full text

Right latissimus dorsi cardiomyoplasty improves left ventricular function by increasing peak systolic elastance (Emax) by Aklog, L, Murphy, M P, Chen, F Y, Smith, W J, Laurence, R G, Appleyard, R F, Cohn, L H

“…Dynamic cardiomyoplasty remains a promising but poorly understood surgical modality for selected patients with dilated cardiomyopathy. Despite encouraging…”
Get full text